18 January 2012 - South Korean Green Cross said last week it had obtained approval in Korea for its orphan drug Hunterase for Hunter syndrome.

According to the company, the only available drug for this rare disease until now has been Shire's (LON:SHP) Elaprase (idursulfase).

T...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up